Skip to main content
Top
Published in: Cancer Causes & Control 6/2016

01-06-2016 | Short Communication

Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck

Authors: Annika Antonsson, Matthew H. Law, Rachel E. Neale, William B. Coman, David I. Pryor, Sandro V. Porceddu, David C. Whiteman, Study of Digestive Health (SDH)

Published in: Cancer Causes & Control | Issue 6/2016

Login to get access

Abstract

Purpose

There is a growing association of human papillomavirus (HPV) with some cases of mucosal squamous cell carcinoma of the head and neck (HNSCC), particularly of the oropharynx. Persistent oral HPV infection is believed to increase the likelihood of malignancy, and it is possible that host genetic factors can determine susceptibility to persistent HPV infection. Polymorphisms in the two EV genes (EVER1 and EVER2, also known as transmembrane channel protein (TMC) 6 and 8) have been identified as strong candidate genes, since a small number of critical mutations in these genes have been shown to cause profound and florid skin HPV infections, and some of them have been linked to susceptibility to cervical cancer.

Methods

We sought to determine whether there was a difference in the frequency of single nucleotide polymorphisms (SNPs) in EVER1 (rs2613516, rs12449858) and EVER2 (rs7205422, rs12452890) between HNSCC patients with HPV-positive and HPV-negative tumors, and healthy controls. We used logistic regression to analyze SNPs in 219 patients with histologically confirmed primary SCC of the oropharynx, oral cavity, hypopharynx, or larynx, and 321 healthy controls.

Results

We did not find any associations with the EVER1/EVER2 SNPs and HPV status or being a HNSCC case or a control.

Conclusions

The present data do not provide evidence for a role of genetic variations in EVER1 or EVER2 for HPV status of mucosal HNSCC or between HNSCC patients and controls.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jablonska S, Dabrowski J, Jakubowicz K (1972) Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 32:583–589PubMed Jablonska S, Dabrowski J, Jakubowicz K (1972) Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Cancer Res 32:583–589PubMed
2.
go back to reference Jablonska S, Majewski S (1994) Epidermodysplasia verruciformis: immunological and clinical aspects. Curr Top Microbiol Immunol 186:157–175PubMed Jablonska S, Majewski S (1994) Epidermodysplasia verruciformis: immunological and clinical aspects. Curr Top Microbiol Immunol 186:157–175PubMed
3.
go back to reference Majewski S, Jablonska S, Orth G (1997) Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin Dermatol 15:321–334CrossRefPubMed Majewski S, Jablonska S, Orth G (1997) Epidermodysplasia verruciformis. Immunological and nonimmunological surveillance mechanisms: role in tumor progression. Clin Dermatol 15:321–334CrossRefPubMed
4.
go back to reference Majewski S, Malejczyk J, Jablonska S et al (1990) Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 22:423–427CrossRefPubMed Majewski S, Malejczyk J, Jablonska S et al (1990) Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 22:423–427CrossRefPubMed
5.
go back to reference Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M (2008) Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 205:35–42CrossRefPubMedPubMedCentral Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M (2008) Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 205:35–42CrossRefPubMedPubMedCentral
6.
go back to reference Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579–581CrossRefPubMed Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579–581CrossRefPubMed
7.
go back to reference Patel AS, Karagas MR, Pawlita M, Waterboer T, Nelson HH (2008) Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case–control study. Int J Cancer 122:2377–2379CrossRefPubMedPubMedCentral Patel AS, Karagas MR, Pawlita M, Waterboer T, Nelson HH (2008) Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case–control study. Int J Cancer 122:2377–2379CrossRefPubMedPubMedCentral
8.
go back to reference Castro FA, Ivansson EL, Schmitt M et al (2012) Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility. Int J Cancer 130:349–355CrossRefPubMed Castro FA, Ivansson EL, Schmitt M et al (2012) Contribution of TMC6 and TMC8 (EVER1 and EVER2) variants to cervical cancer susceptibility. Int J Cancer 130:349–355CrossRefPubMed
9.
go back to reference Stanley MA, Pett MR, Coleman N (2007) HPV: from infection to cancer. Biochem Soc Trans 35:1456–1460CrossRefPubMed Stanley MA, Pett MR, Coleman N (2007) HPV: from infection to cancer. Biochem Soc Trans 35:1456–1460CrossRefPubMed
10.
11.
go back to reference Kendall BJ, Macdonald GA, Hayward NK et al (2008) Leptin and the risk of Barrett’s oesophagus. Gut 57:448–454CrossRefPubMed Kendall BJ, Macdonald GA, Hayward NK et al (2008) Leptin and the risk of Barrett’s oesophagus. Gut 57:448–454CrossRefPubMed
12.
go back to reference Antonsson A, Neale RE, Boros S et al (2015) Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia. Cancer Epidemiol 39:174–181CrossRefPubMed Antonsson A, Neale RE, Boros S et al (2015) Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia. Cancer Epidemiol 39:174–181CrossRefPubMed
14.
go back to reference Levine DM, Ek WE, Zhang R et al (2013) A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett’s esophagus. Nat Genet 45:1487–1493CrossRefPubMedPubMedCentral Levine DM, Ek WE, Zhang R et al (2013) A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett’s esophagus. Nat Genet 45:1487–1493CrossRefPubMedPubMedCentral
15.
go back to reference Gardner MJ, Altman DG (1989) Statistics with confidence—confidence intervals and statistical guidelines. British Medical Journal, London Gardner MJ, Altman DG (1989) Statistics with confidence—confidence intervals and statistical guidelines. British Medical Journal, London
16.
go back to reference Team RDC (2011) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna Team RDC (2011) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
17.
go back to reference Hong AM, Grulich AE, Jones D et al (2010) Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 28:3269–3272CrossRefPubMed Hong AM, Grulich AE, Jones D et al (2010) Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 28:3269–3272CrossRefPubMed
18.
go back to reference D’Souza G, Kreimer AR, Viscidi R et al (2007) Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944–1956CrossRefPubMed D’Souza G, Kreimer AR, Viscidi R et al (2007) Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944–1956CrossRefPubMed
19.
go back to reference Hocking JS, Stein A, Conway EL et al (2011) Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104:886–891CrossRefPubMedPubMedCentral Hocking JS, Stein A, Conway EL et al (2011) Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104:886–891CrossRefPubMedPubMedCentral
20.
go back to reference Liang C, Kelsey KT, McClean MD et al (2015) A coding variant in TMC8 (EVER2) is associated with high risk HPV infection and head and neck cancer risk. PLoS One 10:e0123716CrossRefPubMedPubMedCentral Liang C, Kelsey KT, McClean MD et al (2015) A coding variant in TMC8 (EVER2) is associated with high risk HPV infection and head and neck cancer risk. PLoS One 10:e0123716CrossRefPubMedPubMedCentral
21.
go back to reference Horn H, Pott C, Kalla J et al (2010) A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens. Pharmacogenet Genomics 20:598–604CrossRefPubMed Horn H, Pott C, Kalla J et al (2010) A multiplex MALDI-TOF MS approach facilitates genotyping of DNA from formalin-fixed paraffin-embedded tumour specimens. Pharmacogenet Genomics 20:598–604CrossRefPubMed
22.
go back to reference Genomes Project C, Abecasis GR, Altshuler D et al (2010) A map of human genome variation from population-scale sequencing. Nature 467:1061–1073CrossRef Genomes Project C, Abecasis GR, Altshuler D et al (2010) A map of human genome variation from population-scale sequencing. Nature 467:1061–1073CrossRef
24.
go back to reference Pruitt KD, Tatusova T, Maglott DR (2005) NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 33:D501–D504CrossRefPubMed Pruitt KD, Tatusova T, Maglott DR (2005) NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 33:D501–D504CrossRefPubMed
Metadata
Title
Variants of EVER1 and EVER2 (TMC6 and TMC8) and human papillomavirus status in patients with mucosal squamous cell carcinoma of the head and neck
Authors
Annika Antonsson
Matthew H. Law
Rachel E. Neale
William B. Coman
David I. Pryor
Sandro V. Porceddu
David C. Whiteman
Study of Digestive Health (SDH)
Publication date
01-06-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 6/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0749-y

Other articles of this Issue 6/2016

Cancer Causes & Control 6/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine